This year’s San Antonio Breast Cancer Symposium featured several high-impact abstracts.
Findings of potentially practice-changing studies highlighted the benefit of new therapeutic regimens and the potential to de-escalate treatment for certain patients.
Healio presents this overview of some of the important SABCS research that may be relevant to your practice.
1. Treatment de-escalation may be possible for patients with breast cancer who respond well to neoadjuvant chemotherapy. The findings help provide clarity to an active debate about optimal postsurgical treatment for patients who